Cystadenocarcinoma, Serous - 13 Studies Found

Completed : Papillary Serous Carcinoma of the Endometrium
: Endometrial Cancer
: 2007-08-09
:
  • Drug: Paclitaxel 50 mg/m^2 IV

Completed : A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
: Uterine Cancer
: 2005-10-03
:
  • Drug: Carboplatin and Paclitaxel and Pelvic Radiation Therapy

Completed : Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
: Uterine Cancer
: 2007-07-23
:
  • Drug: Imatinib Mesylate

Not yet recruiting : Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
:
  • Endometrial Serous Adenocarcinoma
  • Stage IIIA Uterine Corpus Can
    : 2014-04-10
    :
    • Drug: Paclitaxel Given IV
Completed : To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers
:
  • Pancreatic Adenocarcinoma Metastatic
  • Ovarian Serous Adenocarcinoma : 2014-07-01
    : Drug: Plerixafor A continuous 7 day intravenous infusion, starting at a dose of 20 ug/kg/hr, and subsequ
Completed : Phase II ABT-888 With Cyclophosphamide
:
  • Ovarian Cancer
  • Primary Peritoneal Cancer
  • Drug: ABT-888 PARP enzymes are
Recruiting : Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
:
  • Micropapillary Serous Carcinoma
  • Ovarian S
    : 2014-03-28
    :
    • Other: Laboratory Biomarker Analysis

Completed : Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
:
: 2025-07-31
Completed : Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System
: Ovarian Cancer
: 2009-02-05
Active, not recruiting : Radical Fimbriectomy for Young BRCA Mutation Carriers
:
  • BRCA1 Mutation
  • BRCA2 Mutation

: 2012-05-15
:
  • Procedure: Radical fimbriectomy

Next >>>